Cost-Effectiveness of Zoledronic Acid Versus Alendronic Acid In The Treatment of Osteoporosis In Postmenopausal Egyptian Patients: Decision Analysis

To evaluate from the Ministry of Health perspective, over a five-year period, the cost-effectiveness of using zoledronic acid 5mg compared to that of alendronic acid in the treatment of osteoporosis in postmenopausal Egyptian patients.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: H Elmansy, AB Metry, R Eldessouki, G Elsisi Source Type: research